How many times have you stared at a home COVID-19 test, waiting for the faint line that confirms an infection? Those home antigen tests often fail to detect a recent infection or one with no symptoms. A PCR test is more accurate, but it must be done by a medical lab and the results take days to deliver.
Having lived with an ALS diagnosis since 2018, Kate Nycz can tell you firsthand what it’s like to slowly lose motor function for basic tasks. “My arm can get to maybe 90 degrees, but then it fatigues and falls,” the 39-year-old said. “To eat or do a repetitive motion with my right hand, which was my dominant hand, is difficult. I’ve mainly become left-handed.”
Patients with some cancers, autoimmune diseases, and metabolic disorders often endure time-consuming intravenous (IV) infusions to receive the best protein-based treatments available. Because these protein therapeutics require high doses to be effective and are typically formulated at low concentrations to remain stable, IV infusion has been, until now, the only option.
Researchers from the University of California San Diego Sanford Stem Cell Institute have developed a novel method to stimulate and mature human brain organoids using graphene, a one-atom-thick sheet of carbon.
Researchers develop a fast-acting, cell-permeable protein system to control CRISPR-Cas9, reducing off-target effects and advancing gene therapy.
OSTRAVA, Czech Republic, Aug. 19, 2025 /PRNewswire/ — Stimvia, a medtech company based in the Czech Republic, has successfully completed a clinical study on peroneal electrical transcutaneous neuromodulation (peroneal eTNM®) through its URIS® device to treat Parkinson’s disease symptoms.
Datasea, a Nevada-based technology enterprise specialising in advanced acoustic high-tech products and AI multimodal digital solutions, today announced a milestone breakthrough in its acoustic technology
A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection rates.
A team of researchers at the University of Oxford have unveiled a pioneering “microstent” which could revolutionize treatment for glaucoma, a common but debilitating condition. The study has been published in The Innovation.
By analyzing millions of messenger RNA molecules (mRNA) during the course of ALS, researchers at Stockholm University, in collaboration with scientists at the Paris Brain Institute and Örebro University, have identified why certain nerve cells are resistant to the disease and what happens in the sensitive nerve cells when they are affected.